RecallDepth
Class III Terminated

Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.

Company
Pfizer Inc.
Recall Initiated
December 2, 2015
Posted
December 16, 2015
Recall Number
D-0520-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 4005 bottles, b) 104 bottles
Firm Location
New York, NY, United States

Reason for Recall

Failed Dissolution Specification

Distribution

Nationwide

Lot / Code Info

Lot #: C150065; C150064, Exp 6/16

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class III Drug recalls